Loading
Launch Special: Analyst checkout is open at $29/mo (50% off regular price). Start checkout →
Jiangxi Brother Pharmaceutical Co. filed a Rule 56.2 motion for judgment on the agency record at the U.S. Court of International Trade, contesting a U.S. government trade remedy decision; Solvay USA, LLC is participating as defendant-intervenor. The government's response is due 5/22/2026.